These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 7522176

  • 21. Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP.
    Bushfield M, McNicol A, MacIntyre DE.
    Biochem J; 1985 Nov 15; 232(1):267-71. PubMed ID: 3002327
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA, Lawrence RA, Jones RL, Wilson NH, Collier A.
    Br J Pharmacol; 1989 Jul 15; 97(3):657-68. PubMed ID: 2474350
    [Abstract] [Full Text] [Related]

  • 24. Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils.
    Armstrong RA.
    Br J Pharmacol; 1995 Dec 15; 116(7):2903-8. PubMed ID: 8680723
    [Abstract] [Full Text] [Related]

  • 25. The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl-methionyl-leucyl-phenylalanine.
    Gryglewski RJ, Szczeklik A, Wandzilak M.
    Biochem Pharmacol; 1987 Dec 15; 36(24):4209-13. PubMed ID: 2446631
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Platelet enhancement of O2-. responses in stimulated human neutrophils. Identification of platelet factor as adenine nucleotide.
    Ward PA, Cunningham TW, McCulloch KK, Phan SH, Powell J, Johnson KJ.
    Lab Invest; 1988 Jan 15; 58(1):37-47. PubMed ID: 2826882
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Characterization of the inhibitory prostanoid receptors on human neutrophils.
    Wheeldon A, Vardey CJ.
    Br J Pharmacol; 1993 Apr 15; 108(4):1051-4. PubMed ID: 8387383
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils.
    Koike H, Imanishi N, Natsume Y, Morooka S.
    Eur J Pharmacol; 1994 Nov 15; 269(3):299-309. PubMed ID: 7895770
    [Abstract] [Full Text] [Related]

  • 32. Ca2+ ionophore-induced cyclic adenosine-3',5'-monophosphate elevation in human neutrophils. A calmodulin-dependent potentiation of adenylate cyclase response to endogenously produced adenosine: comparison to chemotactic agents.
    Iannone MA, Wolberg G, Zimmerman TP.
    Biochem Pharmacol; 1991 Dec 11; 42 Suppl():S105-11. PubMed ID: 1662948
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Characterization of prostanoid receptors on rat neutrophils.
    Wise H, Jones RL.
    Br J Pharmacol; 1994 Oct 11; 113(2):581-7. PubMed ID: 7834211
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of the production of platelet activating factor and of leukotriene B4 in activated neutrophils by nimesulide due to an elevation of intracellular cyclic adenosine monophosphate.
    Tool AT, Verhoeven AJ.
    Arzneimittelforschung; 1995 Oct 11; 45(10):1110-4. PubMed ID: 8595070
    [Abstract] [Full Text] [Related]

  • 36. The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase.
    Trist DG, Collins BA, Wood J, Kelly MG, Robertson AD.
    Br J Pharmacol; 1989 Feb 11; 96(2):301-6. PubMed ID: 2466517
    [Abstract] [Full Text] [Related]

  • 37. Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils.
    Talpain E, Armstrong RA, Coleman RA, Vardey CJ.
    Br J Pharmacol; 1995 Apr 11; 114(7):1459-65. PubMed ID: 7606349
    [Abstract] [Full Text] [Related]

  • 38. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets.
    Yu SM, Chen CC, Ko FN, Huang YL, Huang TF, Teng CM.
    Biochem Pharmacol; 1992 Jan 22; 43(2):323-9. PubMed ID: 1310852
    [Abstract] [Full Text] [Related]

  • 39. Studies on antiplatelet effects of OP-41483, a prostaglandin I2 analog, in experimental animals. II. Mechanism of its antiplatelet effect.
    Fujitani B, Wakitani K.
    Jpn J Pharmacol; 1990 May 22; 53(1):25-33. PubMed ID: 2161965
    [Abstract] [Full Text] [Related]

  • 40. Synergistic inhibition of human polymorphonuclear function by prostaglandin E1 and linsidomine.
    Gladis-Villanueva M, Schrör K.
    J Pharm Pharmacol; 1996 Jul 22; 48(7):706-11. PubMed ID: 8866334
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.